have people died from semaglutide Study finds weight loss drug reduced COVID-19 related deaths during the pandemic Cardiovascular Disease | Ozempic® (semaglutide)

What the research actually covers Characterised as the first selective compound of its class (Raun et al., 1998) Comparatively little effect on cortisol and prolactin No human trials measure whether it builds muscle or improves strength Mechanism is well described

And a significant group needs ongoing therapy to sustain their progress

Indefinitely until it reaches the fill line, as long as the lid is intact and the container is upright and out of reach of children and pets

Dual and triple agonists aim to: Reduce intake Increase energy expenditure Improve metabolic flexibility Address insulin resistance This multi-mechanism approach reflects modern understanding of obesity pathophysiology